Squarepoint’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,778
| Closed | -$31.7K | – | 2816 |
|
|
2025
Q1 | $31.7K | Buy |
34,778
+15,098
| +77% | +$13.8K | ﹤0.01% | 2656 |
|
|
2024
Q4 | $21.5K | Buy |
+19,680
| New | +$21.5K | ﹤0.01% | 2705 |
|
|
2024
Q3 | – | Sell |
-57,318
| Closed | -$71.1K | – | 2623 |
|
|
2024
Q2 | $71.1K | Sell |
57,318
-58,834
| -51% | -$73K | ﹤0.01% | 2324 |
|
|
2024
Q1 | $220K | Buy |
116,152
+72,540
| +166% | +$137K | ﹤0.01% | 2054 |
|
|
2023
Q4 | $115K | Buy |
43,612
+24,709
| +131% | +$65.2K | ﹤0.01% | 2253 |
|
|
2023
Q3 | $43.5K | Buy |
+18,903
| New | +$43.5K | ﹤0.01% | 2340 |
|
|
2023
Q2 | – | Sell |
-20,233
| Closed | -$72.2K | – | 2468 |
|
|
2023
Q1 | $72.2K | Buy |
+20,233
| New | +$72.2K | ﹤0.01% | 2074 |
|
|
2021
Q1 | – | Sell |
-26,205
| Closed | -$328K | – | 2647 |
|
|
2020
Q4 | $328K | Buy |
26,205
+6,270
| +31% | +$78.5K | ﹤0.01% | 1798 |
|
|
2020
Q3 | $300K | Buy |
+19,935
| New | +$300K | ﹤0.01% | 1680 |
|